AXR vs XRAY · P/E 11, rev $52.8M vs rev $1.78B
AMREP Corporation (AXR) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
AMREP Corporation (AXR) is a real estate - development company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported AXR revenue for 2026-04-30 was $52.8M. Net income was $10.3M. Revenue was up 6.3% from 2025-04-30 to 2026-04-30. AXR currently screens at market cap $135.4M and trailing P/E 10.6.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
AXR currently screens at market cap $135.4M and trailing P/E 10.6. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the AXR and XRAY stock pages for the full models.
Not investment advice.